An analysis of prospectively collected multi-centre data.
Consecutive data for patients undergoing CEA between January-2006 and September-2010 were collected. Asymptomatic patients and those with no details on the timing of cerebral symptoms were excluded.
鈥楧elay鈥?from symptom to CEA was defined as more than two weeks and 鈥榩rolonged-delay鈥?more than eight weeks. Univariable and multivariable analyses were used to identify factors associated with these delays.
Of 2147 patients with symptoms of cerebral ischaemia, 1522(70.9%) experienced 鈥榙elay鈥?and 920(42.9%) experienced 鈥榩rolonged delay鈥? Patients with ischaemic heart disease were more likely to experience 鈥榙elay鈥?(OR聽=聽1.56; 95%CI 1.11-2.19, p聽=聽0.011), whereas patients with stroke (OR聽=聽0.77; 95%CI 0.63-0.94, p聽=聽0.011) and those treated at hospitals with a stroke-prevention clinic (OR聽=聽0.57; 95%CI 0.46-0.71, p聽<聽0.001) were less likely to experience 鈥榙elay鈥? Patients treated after the publication of National Institute for Health and Clinical Excellence (NICE) guidelines were less likely to experience 鈥榩rolonged delay鈥?(OR聽=聽0.77; 95%CI 0.65-0.91, p聽=聽0.003) but not 鈥榙elay鈥?
Few patients achieved CEA within two weeks of symptoms. Introducing stroke-prevention clinics with one-stop carotid imaging appears important.